The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Aug 2023)
Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS
Jeanne M. Schilder,
Amanda Golembesky,
Tirza Areli Calderón Boyle,
Gui Lan Ye,
Judi Kuplast
Affiliations
Jeanne M. Schilder
GSK, Philadelphia, PA, United States
Amanda Golembesky
GSK, Durham, NC, United States
Tirza Areli Calderón Boyle
GSK, Collegeville, PA, United States
Gui Lan Ye
GSK, Collegeville, PA, United States
Judi Kuplast
GSK, Collegeville, PA, United States
DOI
https://doi.org/10.3389/fphar.2023.1241524
Journal volume & issue
Vol. 14
Abstract
Read online
No abstracts available.
Keywords
niraparib
PARP inhibitors
pharmacovigilance
FAERS
lymphangioleiomyomatosis
WeChat QR code
Close
